LBPH - longboardpharma.com Operating profit before depreciation charges
Longboard Pharmaceuticals (LBPH) is targeting expansion within the rare neurological pathology segment by scaling bexicaserin. A high concentration of R&D prior to acquisition by a pharma behemoth is accelerating Phase 3 trials. The company's operating profit visualizes these processes, where shows the current volume of this metric. Strict medical logistics ensure the reliability of drug supplies, guaranteeing business stability.
Summary analytical data breakdowns for Longboard Pharmaceuticals, Inc. (LBPH)
- share price and expert price forecast:
- market capitalization statistics:
- company book value details:
- business debt structure and liquidity details:
Total Debt to Capital Longboard Pharmaceuticals|LBPH - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Longboard Pharmaceuticals Inc|LBPH - Company Aggregate Debts|Debt to Book Value Ratio Longboard Pharmaceuticals|LBPH - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Longboard Pharmaceuticals|Critical Liquidity Ratio longboardpharma.com
- net income and valuation multiples indicators:
LBPH - Net Profit|Expected Net Income Longboard Pharmaceuticals|LBPH - P/E Multiple|Forward P/E Multiple longboardpharma.com|LBPH - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Longboard Pharmaceuticals|LBPH - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Longboard Pharmaceuticals|LBPH - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth longboardpharma.com|LBPH - Earnings growth in current year|Expected earnings per share growth for next year Longboard Pharmaceuticals
Summary company analytics:Longboard - LBPH
This indicator captures real-time cash flow from core operations, eliminating the time lags of standard reporting to promptly identify profitability trends. The current absolute operating profit value stands at , allowing for a real-time assessment of the financial stability of Longboard Pharmaceuticals (LBPH) amid the development of selective drugs for the treatment of epilepsy and rare neurological diseases.
Competitor analysis for Longboard Pharmaceuticals
BIIB: Operating profit before amortization|Neurocrine Biosciences - Operating profit EBITDA|Operating profit before depreciation charges regencellbioscience.com (RGC)|AXSM: Operating profit EBITDA|ACAD (ACADIA Pharma) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Profit before interest, taxes and amortization Viking Therapeutics Corp VKTX|Operating profit EBITDA SUPN|Operating profit EBITDA catalystpharma.com (CPRX)|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|Income before deduction of interest, taxes and amortization HRMY|Biohaven Pharmaceutical - Operating profit EBITDA|AMLX (Amylyx Corp) - Operating profit before amortization|TRVI (Trevi Therapeutics) - Operating profit before deduction of amortization|praxismedicines.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Anavex Life Sciences Corp.|CeriBell Inc - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA PRTA|ALEC (alector.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANNX (Annexon, Inc.)|Operating profit EBITDA Omeros Corp OMER|NGNE - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization ACIU (AC Immune S.A.)|Voyager Pharma (VYGR) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Neumora Corp|SCLX (Scilex Holding Company) - Operating profit EBITDA|Operating profit EBITDA tevogen.com|Operating profit EBITDA ACOG|Operating profit before deduction of amortization Cognition Therapeutics Inc. CGTX|Operating profit EBITDA IKT (Inhibikase)|Cassava Pharma (SAVA) - Profit before interest, taxes and amortization|ASRT: Operating profit before deduction of amortization|COYA - Operating profit EBITDA|VTGN (vistagen.com) - Operating profit before deduction of amortization|OVID: Company profit before taxes, interest and amortization|ABOS (Acumen Pharma) - Operating profit EBITDA|CervoMed Corporation (CRVO) - Operating income before deduction of amortization|Operating profit EBITDA ATHE|Operating profit before deduction of amortization clene.com CLNN|Operating profit EBITDA PEPG (PepGen)|Operating profit EBITDA Jupiter Neurosciences, Inc. JUNS|RLMD - Profit before payment of interest, taxes and amortization|ANVS: Profit before payment of interest, taxes and amortization|gracetx.com (GRCE) - Profit before payment of interest, taxes and amortization|AIFF - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization ANEW Medical|Profit before payment of interest, taxes and amortization NRSN|Operating profit EBITDA RVPH|Profit before payment of interest, taxes and amortization MTVA (metaviatx.com)|Profit before payment of interest, taxes and amortization NeurAxis, Inc. NRXS|HSDT (Helius Medical Technologies, Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|Passage Bio Corp - Operating profit EBITDA|Income before deduction of interest, taxes and amortization NEUP (Neuphoria Therapeutics Inc.)|Minerva Neurosciences Corp (NERV) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ATHA|ADXN (Addex Therapeutics) - Operating profit EBITDA|Profit before interest, taxes and amortization Alzamend ALZN|Operating profit before deduction of amortization CYCN (Cyclerion Therapeutics)|Operating profit EBITDA protagenic.com (PTIX)|Profit before payment of interest, taxes and amortization Pasithea Therapeutics Corp. KTTA|Income before deduction of interest, taxes and amortization CRGT|ATXI - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization brainstorm-cell.com|Cara Therapeutics (CARA) - Profit before payment of interest, taxes and amortization|CHRO (Chromocell Therapeutics Corp) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Eliem Therapeutics, Inc.|Profit before interest, taxes and amortization Intra-Cellular ITCI|Profit before payment of interest, taxes and amortization Marinus Pharmaceuticals (MRNS)|nkgenbiotech.com - Operating profit before amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Operating profit before depreciation charges Sage Therapeutics Inc.|Neurotrope - Operating profit EBITDA|TRVN: Profit before payment of interest, taxes and amortization|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization anewmeds.com (WENA)|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
